Ryzodeg QUIZ May 2023

Ryzodeg QUIZ May 2023

Professional Development

20 Qs

quiz-placeholder

Similar activities

NPS Boot Camp

NPS Boot Camp

Professional Development

20 Qs

General Knowledge

General Knowledge

Professional Development

16 Qs

Fertility Knowledge Challenge_March 2018

Fertility Knowledge Challenge_March 2018

Professional Development

15 Qs

English for Nursing - Hospital Departments (Pair)

English for Nursing - Hospital Departments (Pair)

University - Professional Development

20 Qs

CHERY OSS QUIZ

CHERY OSS QUIZ

Professional Development

15 Qs

Internationl patient safety Goals

Internationl patient safety Goals

Professional Development

15 Qs

Nursing Informatics (Nurses/PSA/OA/OT)

Nursing Informatics (Nurses/PSA/OA/OT)

Professional Development

15 Qs

BET V.1

BET V.1

Professional Development

15 Qs

Ryzodeg QUIZ May 2023

Ryzodeg QUIZ May 2023

Assessment

Quiz

Other

Professional Development

Easy

Created by

Salman Anzar

Used 6+ times

FREE Resource

20 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

In step by step trial primary end point was Change from baseline in HbA1c after 26 weeks.

True

False

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Nocturnal confirmed hypoglycaemia with IDegAsp lower in step by step trial after 26 weeks was ____ and after 38 weeks was ____ ?

43%, 34%

45%, 39%

41%, 14%

None of these

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

In step by step trial patients included treated with regimen like.

OADs

Basal Insulin

Basal Bolus Insulin

on Premix Insulins in previous 3 months

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Initial Starting dose of Insulin Aspart in Step by Step intensification trial was

4 Units

6 Units

8 Units

According to Body weight

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Confirmed hypoglycaemia in step by step intensification trial ____ lower at week 26, ____ lower at week 38.

14%, 10%

12%, 14%

10%, 14%

15%,20%

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Total number of patients included in step by step intensification trial.

521 patients

532 patients

582 patients

696 patients

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

CONFIRM trial is comparative effectiveness of degludec (either 100 or 200 units/mL) versus glargine U300 in insulin-naïve adult patients with T2D.

True

False

Create a free account and access millions of resources

Create resources
Host any resource
Get auto-graded reports
or continue with
Microsoft
Apple
Others
By signing up, you agree to our Terms of Service & Privacy Policy
Already have an account?